Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis.
Hua JiangLu LiMeiyu GuoMeizhang LiHao WuXiaomei ChenMingzhao GaoQianqian XuJia MiCanchan CuiWeijun FuPublished in: Hematology (Amsterdam, Netherlands) (2024)
Our results indicate that MM patients with RI could benefit from a daratumumab-added regimen regardless of MM status. Additional high-quality RCTs are still warranted to confirm our findings.
Keyphrases